LifePoint Health, Inc. (LPNT) Expected to Post Quarterly Sales of $1.60 Billion
Brokerages predict that LifePoint Health, Inc. (NASDAQ:LPNT) will post $1.60 billion in sales for the current quarter, Zacks reports. Eight analysts have issued estimates for LifePoint Health’s earnings. The lowest sales estimate is $1.58 billion and the highest is $1.61 billion. LifePoint Health reported sales of $1.59 billion in the same quarter last year, which indicates a positive year over year growth rate of 0.6%. The company is scheduled to report its next quarterly earnings report on Friday, October 27th.
According to Zacks, analysts expect that LifePoint Health will report full-year sales of $1.60 billion for the current financial year, with estimates ranging from $6.44 billion to $6.49 billion. For the next financial year, analysts forecast that the firm will report sales of $6.61 billion per share, with estimates ranging from $6.48 billion to $6.72 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research analysts that that provide coverage for LifePoint Health.
LifePoint Health (NASDAQ:LPNT) last released its quarterly earnings results on Tuesday, August 1st. The company reported $0.96 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.90 by $0.06. The company had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.64 billion. LifePoint Health had a return on equity of 7.40% and a net margin of 2.61%. The business’s revenue for the quarter was up .2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.69 earnings per share.
A number of research firms have commented on LPNT. BidaskClub lowered shares of LifePoint Health from a “buy” rating to a “hold” rating in a research report on Saturday, July 8th. Zacks Investment Research lowered shares of LifePoint Health from a “hold” rating to a “sell” rating in a research report on Tuesday, September 5th. ValuEngine upgraded shares of LifePoint Health from a “hold” rating to a “buy” rating in a research report on Thursday, August 17th. Royal Bank Of Canada restated a “buy” rating and issued a $77.00 price target on shares of LifePoint Health in a research report on Wednesday, July 5th. Finally, Leerink Swann upgraded shares of LifePoint Health from a “market perform” rating to an “outperform” rating and boosted their price target for the company from $73.00 to $74.00 in a research report on Tuesday, June 6th. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $66.18.
Shares of LifePoint Health (LPNT) opened at 56.60 on Friday. The stock’s 50 day moving average price is $57.49 and its 200-day moving average price is $61.98. The company has a market cap of $2.27 billion, a PE ratio of 12.67 and a beta of 0.85. LifePoint Health has a 12-month low of $50.60 and a 12-month high of $70.95.
COPYRIGHT VIOLATION WARNING: “LifePoint Health, Inc. (LPNT) Expected to Post Quarterly Sales of $1.60 Billion” was first reported by American Banking News and is owned by of American Banking News. If you are accessing this article on another domain, it was stolen and reposted in violation of international copyright & trademark law. The legal version of this article can be accessed at https://www.americanbankingnews.com/2017/09/16/lifepoint-health-inc-lpnt-expected-to-post-quarterly-sales-of-1-60-billion.html.
In related news, Chairman William F. Carpenter III sold 17,653 shares of the stock in a transaction that occurred on Monday, July 17th. The shares were sold at an average price of $65.06, for a total value of $1,148,504.18. Following the transaction, the chairman now directly owns 439,841 shares in the company, valued at $28,616,055.46. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 7.28% of the stock is currently owned by corporate insiders.
A number of hedge funds and other institutional investors have recently made changes to their positions in LPNT. BlackRock Inc. lifted its holdings in LifePoint Health by 11,671.9% in the first quarter. BlackRock Inc. now owns 3,745,824 shares of the company’s stock valued at $245,351,000 after buying an additional 3,714,004 shares during the period. LSV Asset Management lifted its holdings in LifePoint Health by 83.5% in the second quarter. LSV Asset Management now owns 1,994,557 shares of the company’s stock valued at $133,934,000 after buying an additional 907,469 shares during the period. Point72 Asset Management L.P. lifted its holdings in LifePoint Health by 291.1% in the first quarter. Point72 Asset Management L.P. now owns 688,352 shares of the company’s stock valued at $45,087,000 after buying an additional 512,352 shares during the period. Victory Capital Management Inc. lifted its holdings in LifePoint Health by 130.6% in the second quarter. Victory Capital Management Inc. now owns 816,147 shares of the company’s stock valued at $54,804,000 after buying an additional 462,211 shares during the period. Finally, Prudential Financial Inc. lifted its holdings in LifePoint Health by 95.2% in the first quarter. Prudential Financial Inc. now owns 560,687 shares of the company’s stock valued at $36,725,000 after buying an additional 273,445 shares during the period. Institutional investors and hedge funds own 99.53% of the company’s stock.
LifePoint Health Company Profile
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.